Shockwave + Pressure Waves + EMTT for Musculoskeletal Injuries

This trial explores the effectiveness of different therapies for treating lower-body injuries, such as those affecting muscles, cartilage, and bones. It tests three treatments: electromagnetic transduction therapy (EMTT), focused shockwave therapy (ESWT), and radial pressure wave therapy (EPAT), both individually and in combination. Individuals with a doctor-confirmed lower-body injury who experience daily difficulties may be suitable candidates. However, those with metal implants or certain other conditions may not qualify for some trial components. As an unphased trial, this study provides a unique opportunity to explore innovative treatments that could enhance quality of life.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Focused Shockwave Therapy (ESWT) is generally safe and well-tolerated. Studies have found it effective for various muscle and joint conditions, with few side effects reported. As a non-invasive treatment, it does not involve surgery or cutting the skin, and most people experience little to no side effects.

Radial Pressure Waves (EPAT) are also considered safe for most people. However, some individuals might not be suitable for this treatment, so discussing any health concerns with a doctor is important. Like ESWT, EPAT is non-invasive and usually well-tolerated.

Electromagnetic Transduction Therapy (EMTT) has shown promise in reducing pain and improving physical function. Reports indicate only minor side effects, making it another safe option for muscle and joint problems. This therapy is also non-invasive, which generally means fewer risks compared to surgery.

Researchers are excited about these treatments for musculoskeletal injuries because they offer innovative approaches that could enhance healing and pain relief. Unlike typical treatments like physical therapy and anti-inflammatory medications, these therapies use advanced technologies. Electromagnetic Transduction Therapy (EMTT) utilizes electromagnetic fields to stimulate cellular repair and reduce inflammation. Focused Shockwave Therapy (ESWT) and Radial Pressure Waves (EPAT) apply targeted mechanical waves to promote tissue regeneration and improve blood circulation. By leveraging these unique mechanisms, these treatments have the potential to provide more effective and quicker recovery options for patients.

Research has shown that Focused Shockwave Therapy (ESWT) can effectively reduce pain and aid in healing bones, tendons, ligaments, and fascia in individuals with musculoskeletal injuries. It often outperforms other treatments, such as hyaluronic acid, particularly in pain relief. In this trial, some participants will receive shock wave therapy alone, while others will receive it combined with Radial Pressure Waves (EPAT) or Electromagnetic Transduction Therapy (EMTT). Radial Pressure Waves (EPAT) have shown promise, with many patients experiencing significant improvements in pain and movement, especially for conditions like plantar fasciitis. Electromagnetic Transduction Therapy (EMTT) has proven effective in enhancing physical function and reducing pain in degenerative musculoskeletal conditions, with few side effects. This trial studies these therapies for their potential to heal and alleviate pain in musculoskeletal injuries.¹³⁶⁷⁸